Trial Profile
REMUNE HIV/AIDS Vaccine Phase II Pediatric Safety & Efficacy Clinical Study
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs GP120-depleted HIV-1 vaccine (Primary)
- Indications HIV infections
- Focus Pharmacodynamics
- Sponsors Immune Response BioPharma
- 22 Feb 2016 Planned End Date changed from 1 Nov 2018 to 1 Nov 2019 as reported by ClinicalTrials.gov record.
- 22 Feb 2016 Planned primary completion date changed from 1 Nov 2018 to 1 Nov 2019 as reported by ClinicalTrials.gov record.
- 22 Feb 2016 Planned initiation date changed from 1 Nov 2016 to 1 Nov 2017 as reported by ClinicalTrials.gov record.